These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32593189)

  • 1. Plasma metabolomic fingerprint of advanced cirrhosis stages among HIV/HCV-coinfected and HCV-monoinfected patients.
    Salgüero S; Rojo D; Berenguer J; González-García J; Fernández-Rodríguez A; Brochado-Kith O; Díez C; Hontañon V; Virseda-Berdices A; Martínez J; Ibañez-Samaniego L; Llop-Herrera E; Barbas C; Resino S; Jiménez-Sousa MA;
    Liver Int; 2020 Sep; 40(9):2215-2227. PubMed ID: 32593189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomic changes after DAAs therapy are related to the improvement of cirrhosis and inflammation in HIV/HCV-coinfected patients.
    Virseda-Berdices A; Rojo D; Martínez I; Berenguer J; González-García J; Brochado-Kith O; Fernández-Rodríguez A; Díez C; Hontañon V; Pérez-Latorre L; Micán R; Barbas C; Resino S; Jiménez-Sousa MA;
    Biomed Pharmacother; 2022 Mar; 147():112623. PubMed ID: 35032770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver function following hepatitis C virus eradication by direct acting antivirals in patients with liver cirrhosis: data from the PITER cohort.
    Quaranta MG; Ferrigno L; Tata X; D'Angelo F; Coppola C; Ciancio A; Bruno SR; Loi M; Giorgini A; Margotti M; Cossiga V; Brancaccio G; Dallio M; De Siena M; Cannizzaro M; Cavalletto L; Massari M; Mazzitelli M; De Leo P; Laccabue D; Baiocchi L; Kondili LA
    BMC Infect Dis; 2021 May; 21(1):413. PubMed ID: 33947337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma IP-10 and IL-6 are linked to Child-Pugh B cirrhosis in patients with advanced HCV-related cirrhosis: a cross-sectional study.
    Salgüero S; Medrano LM; González-García J; Berenguer J; Montes ML; Diéz C; Garcia-Broncano P; Llop-Herrera E; Pérez-Latorre L; Bellóno JM; Jiménez-Sousa MÁ; Resino S
    Sci Rep; 2020 Jun; 10(1):10384. PubMed ID: 32587340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis.
    Pineda JA; Romero-Gómez M; Díaz-García F; Girón-González JA; Montero JL; Torre-Cisneros J; Andrade RJ; González-Serrano M; Aguilar J; Aguilar-Guisado M; Navarro JM; Salmerón J; Caballero-Granado FJ; García-García JA; ;
    Hepatology; 2005 Apr; 41(4):779-89. PubMed ID: 15800956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis.
    Merchante N; Rivero-Juárez A; Téllez F; Merino D; José Ríos-Villegas M; Márquez-Solero M; Omar M; Macías J; Camacho A; Pérez-Pérez M; Gómez-Mateos J; Rivero A; Antonio Pineda J;
    Hepatology; 2012 Jul; 56(1):228-38. PubMed ID: 22278746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between alcohol use categories and noninvasive markers of advanced hepatic fibrosis in HIV-infected, chronic hepatitis C virus-infected, and uninfected patients.
    Lim JK; Tate JP; Fultz SL; Goulet JL; Conigliaro J; Bryant KJ; Gordon AJ; Gibert C; Rimland D; Goetz MB; Klein MB; Fiellin DA; Justice AC; Lo Re V
    Clin Infect Dis; 2014 May; 58(10):1449-58. PubMed ID: 24569533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of and factors associated with hepatocellular carcinoma among hepatitis C virus and human immunodeficiency virus coinfected patients with decompensated cirrhosis.
    García-García JA; Romero-Gómez M; Girón-González JA; Rivera-Irigoin R; Torre-Cisneros J; Montero JL; González-Serrano M; Andrade RJ; Aguilar-Guisado M; Grilo I; Martín-Vivaldi J; Salmerón J; Caballero-Granado FJ; Macías J; Vergara-López S; Pineda JA; ;
    AIDS Res Hum Retroviruses; 2006 Dec; 22(12):1236-41. PubMed ID: 17209765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Untargeted Plasma Metabolomics Reveals Extensive Metabolic Alterations Among Treatment-Naive Human Immunodeficiency Virus/Hepatitis C Virus Co-Infected Patients with Liver Disease Progression.
    He J; Liu X; Duan S; Ye R; Yang Y; Wang J; He N
    AIDS Res Hum Retroviruses; 2022 May; 38(5):378-393. PubMed ID: 35383478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver Stiffness-Based Strategies Predict Absence of Variceal Bleeding in Cirrhotic Hepatitis C Virus-Infected Patients With and Without Human Immunodeficiency Virus Coinfection After Sustained Virological Response.
    Corma-Gómez A; Macías J; Morano L; Rivero A; Téllez F; Ríos MJ; Santos M; Serrano M; Palacios R; Merino D; Real LM; De Los Santos I; Vera-Méndez FJ; Galindo MJ; Pineda JA;
    Clin Infect Dis; 2021 Mar; 72(5):e96-e102. PubMed ID: 33211801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study.
    Lo Re V; Kallan MJ; Tate JP; Localio AR; Lim JK; Goetz MB; Klein MB; Rimland D; Rodriguez-Barradas MC; Butt AA; Gibert CL; Brown ST; Park L; Dubrow R; Reddy KR; Kostman JR; Strom BL; Justice AC
    Ann Intern Med; 2014 Mar; 160(6):369-79. PubMed ID: 24723077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced liver disease outcomes after hepatitis C eradication by human immunodeficiency virus infection in PITER cohort.
    Quaranta MG; Ferrigno L; Monti M; Filomia R; Biliotti E; Iannone A; Migliorino G; Coco B; Morisco F; Vinci M; D'Ambrosio R; Chemello L; Massari M; Ieluzzi D; Russo FP; Blanc P; Verucchi G; Puoti M; Rumi MG; Barbaro F; Santantonio TA; Federico A; Chessa L; Gentile I; Zuin M; Parruti G; Morsica G; Kondili LA;
    Hepatol Int; 2020 May; 14(3):362-372. PubMed ID: 32279177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of HIV, Hepatitis C Virus, and Liver Fibrosis Severity With the Enhanced Liver Fibrosis Score.
    Swanson S; Ma Y; Scherzer R; Huhn G; French AL; Plankey MW; Grunfeld C; Rosenberg WM; Peters MG; Tien PC
    J Infect Dis; 2016 Apr; 213(7):1079-86. PubMed ID: 26621911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rates of sustained virological response 12 weeks after the scheduled end of direct-acting antiviral (DAA)-based hepatitis C virus (HCV) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therapy?
    Bischoff J; Mauss S; Cordes C; Lutz T; Scholten S; Moll A; Jäger H; Cornberg M; Manns MP; Baumgarten A; Rockstroh JK
    HIV Med; 2018 Apr; 19(4):299-307. PubMed ID: 29368456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of HIV infection in patients infected with chronic HCV (genotypes 1a and 3a): virological and clinical changes.
    Behzadpour D; Ahmadi Vasmehjani A; Mousavi Nasab SD; Ahmadi NA; Baharlou R
    Pathog Glob Health; 2016; 110(7-8):310-315. PubMed ID: 27830997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Bone Deficits in HIV/HCV-Coinfected, HCV-Monoinfected, and HIV-Monoinfected Women.
    Lo Re V; Lynn K; Stumm ER; Long J; Nezamzadeh MS; Baker JF; Hoofnagle AN; Kapalko AJ; Mounzer K; Zemel BS; Tebas P; Kostman JR; Leonard MB
    J Infect Dis; 2015 Sep; 212(6):924-33. PubMed ID: 25754980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection.
    Lo Re V; Volk J; Newcomb CW; Yang YX; Freeman CP; Hennessy S; Kostman JR; Tebas P; Leonard MB; Localio AR
    Hepatology; 2012 Nov; 56(5):1688-98. PubMed ID: 22619086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients.
    Fernández-Montero JV; Barreiro P; de Mendoza C; Labarga P; Soriano V
    J Viral Hepat; 2016 Jan; 23(1):47-52. PubMed ID: 26390144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver histopathology in patients with concurrent chronic hepatitis C and HIV infection.
    Bierhoff E; Fischer HP; Willsch E; Rockstroh J; Spengler U; Brackmann HH; Oldenburg J
    Virchows Arch; 1997 Apr; 430(4):271-7. PubMed ID: 9134037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender differences in liver fibrosis and hepatitis C virus-related parameters in patients coinfected with human immunodeficiency virus.
    Collazos J; Cartón JA; Asensi V
    Curr HIV Res; 2011 Jul; 9(5):339-45. PubMed ID: 21827383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.